Lexington, MA, United States of America

Lingyao Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dsm Nutritional Products Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lingyao Li: Innovator in Oligosaccharide Compositions

Introduction

Lingyao Li is a prominent inventor based in Lexington, MA (US). He has made significant contributions to the field of oligosaccharide compositions, focusing on their applications in metabolic therapies. His innovative work aims to address critical health issues related to glucose and lipid levels.

Latest Patents

Lingyao Li holds 1 patent for his invention titled "Oligosaccharide compositions and methods of use." This patent encompasses various aspects related to oligosaccharide compositions and methods for their production. Additionally, it outlines methods for utilizing these compositions as microbiome metabolic therapies to reduce glucose and lipid concentrations, including cholesterol and triglycerides.

Career Highlights

Lingyao Li is associated with Dsm Nutritional Products Inc., where he applies his expertise in oligosaccharide research. His work is pivotal in developing solutions that can potentially improve metabolic health and address related diseases.

Collaborations

Lingyao Li collaborates with esteemed colleagues, including Yves Millet and Jeffrey Meisner. Their combined efforts contribute to advancing research in the field of nutritional products and metabolic therapies.

Conclusion

Lingyao Li's innovative work in oligosaccharide compositions showcases his commitment to improving health outcomes through scientific research. His contributions are vital in the ongoing quest to develop effective therapies for metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…